您要查找的是不是:
- Objective The aim of this study was to describe the interdigestive gastroduodenal motility in patients with decompensated cirrhosis. 摘要目的研究肝硬化失代偿期患者空腹胃肠动力有无异常。
- Objective To study the clinical characteristic and the species of pathogenic bacteria of pulmonary infection in patients with decompensated cirrhosis. 目的探讨失代偿肝硬化并发肺部感染的病原菌的种类及临床特点。
- There was significant difference of TBA between the patients with compensated and those with decompensated cirrhosis (P<0.01). 肝硬化失代偿期患者的TBA水准显著高于代偿期患者(P<0.;01)。
- The document includes guidance for management of patients with compensated and decompensated cirrhosis, as well as liver transplant recipients. 这份文件包括了代偿性和失代偿型肝硬化以及肝移植受体的治疗指南。
- I am optimistic this will happen but we first need data from clinical trials to establish the usefulness of nucleoside analogues in decompensated cirrhosis. 但是我们需要临床试验的数据支持核苷类似物在失代偿肝硬化中的有效性。
- Decompensated cirrhosis complicated with hypersplenism and hypocytosis are related and influence each other, with the latter being an important aggravating cause of the disease. 摘要肝硬化失代偿期并发的脾功能亢进和血细胞减少,互为因素,相互影响,是造成病情进展的重要原因。
- Analysis on Related Factors of Hyponatremia of Decompensation Cirrhosis and Nursing Care 肝硬化失代偿期低钠血症相关因素分析及护理
- Methods The frame of this model was composed of 6 states-chronic hepatitis B (CHB), natural recovery (NR), compensated cirrhosis (CIR),decompensated cirrhosis (DEC), hepatocellular carcinoma (HCC) and death (DEA). 模型框架包含慢性乙型肝炎 (CHB)、自愈 (NR)、代偿性肝硬化 (CIR)、失代偿性肝硬化(DEC)、原发性肝癌 (HCC)和死亡 (DEA)等阶段。
- Antiviral therapy of HCV with interferon and ribavirin is, however, difficult to tolerate, and is associated with poor response rates in patients with decompensated cirrhosis [17]. 但是使用干扰素和利巴韦林联合抗丙肝病毒的疗法难以耐受,而且失代偿性肝硬化患者的治疗响应很差[17]。
- The experimental results showed that diagnostic principles for compensated and decompensated cirrhosis could be automatically drawn from patients with hepatic cirrhosis by decision-tree calculation. 实验结果表明决策树能较好的自动从肝硬化病例中归纳出代偿性和失代偿性肝硬化的诊断规则。
- The International Liver Transplant Society Consensus Conference suggested that patients with decompensated cirrhosis and a MELD score of less than 18 could be considered for antiviral therapy [18]. 国际肝移植学会讨论会议建议,失代偿性肝硬化患者和MELD分数低于18的患者应该考虑进行抗病毒治疗。
- For patients with cirrhosis, treatment should be more aggressive. If they have decompensated cirrhosis, then treat with an oral antiviral and refer for liver transplant evaluation. 患有肝硬化的患者,更应该积极治疗。如果属于失代偿期肝硬化,他们应该用口服抗病毒药物并给与肝脏移植评估。
- Evaluation of Clinical Significance in Determination of Tissue Factor Pathway Inhibitor Lev-els in Plasma with Several Type of Hepatitis and Decompensation Cirrhosis 各类型肝炎及失代偿期肝硬化患者血浆中组织因子途径抑制物测定的临床意义
- Decompensation cirrhosis 肝硬化失代偿
- In patients with advanced fibrosis or cirrhosis, withholding therapy will hasten decompensation and death. 进展期肝纤维化或肝硬化患者不开始治疗可能加速病情进展。
- Clinical study of Lamivudine treatment in patients with decompensated cirrhosis 拉米夫定在失代偿期肝硬化的临床应用研究
- Nonalcoholic fatty liver is the third of hepatopathy, which are danger to people’s health, and it is close to the decompensation of liver cirrhosis. 非酒精性脂肪肝患病率迅猛增高,现已成为危害人类健康的三大肝病之一,并与失代偿期肝硬化、肝功能衰竭、原发性肝癌的发生密切相关。
- Keywords Hepatitis B virus;Decompensated cirrhosis;Lamivndine;Mutation; 乙型肝炎病毒;失代偿期肝硬化;拉米夫定;变异;
- Patients with cirrhosis have significantly shortened life spans and are at risk for decompensation and hepatic failure, as well as the development of hepatocellular carcinoma. 肝硬化患者会明显缩短寿命,并有肝失代偿和肝衰竭的危险,并有发展成肝癌的可能。
- Long-term suppression of serum HBV DNA is likely to reduce progression to cirrhosis and hepatic decompensation and decrease the risk of hepatocellular carcinoma. 长期抑制血清乙肝病毒DNA很可能会减缓肝硬化和肝失代偿的进程,降低发展为肝癌的风险。